Stephen Bennett

Stephen Bennett is a Senior Lecturer at De Montfort University, affiliated with the Faculty of Health and Life Sciences and the Leicester School of Pharmacy. He is based at The Gateway, Leicester, LE1 9BH, and is an active academic with expertise in clinical and neuropharmacology. His work is associated with the Leicester Institute of Pharmaceutical Innovation for Integrated Care (LIPIIC), and he contributes significantly to pharmacy education and research.

His primary research interests include:

• Paediatric prescribing
• Prescribing safety and error prevention
• Extracorporeal membrane oxygenation (ECMO)
• Intravenous nutrition
• Neuropharmacology and molecular pharmacology
• Diabetes and consultation management

His research, while limited in recent publications, shows a strong foundation in neuropharmacological mechanisms, particularly in dopamine modulation and antipsychotic interactions. The available article from 2005 indicates deep engagement with receptor-level pharmacology, suggesting ongoing relevance in CNS drug research and clinical applications.

Bennett is a registered pharmacist and independent prescriber, actively contributing to professional pharmacy standards. He holds memberships in key organizations:

• Royal Pharmaceutical Society
• General Pharmaceutical Council
• British Association for Psychopharmacology
• United Kingdom Clinical Pharmacy Association
• Neonatal and Paediatric Pharmacists Group

He also serves as an external examiner for non-medical prescribing at the University of Salford (2017–present), demonstrating national recognition in pharmacy education. He teaches across the MPharm program and supervises MSc students, particularly in areas such as antimicrobial resistance and allergy. His educational background includes a BSc(Hons) in Pharmacy, a Certificate in Preclinical Psychopharmacology, a Postgraduate Diploma in Clinical Pharmacy, and a PhD in Neuropharmacology. He is involved in research through LIPIIC, focusing on integrated pharmaceutical innovation, especially in high-risk prescribing contexts.